Home > Insider Trading > Filing (0001093557-18-000200)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1466545	Richard Doubleday	6340 Sequence Drive San Diego CA 92121	Evp, Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-08-31	20,830	$0.00	72,287	No	5	J	Direct
Common Stock	Disposition	2018-09-10	2,303	$143.76	69,984	No	4	S	Direct
Common Stock	Disposition	2018-09-10	3,180	$143.76	66,804	No	4	S	Direct
Common Stock	Acquisiton	2018-08-31	20,830	$0.00	20,830	No	5	J	Indirect	by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	J	Direct
No	4	S	Direct
No	4	S	Direct
No	5	J	Indirect	by Trust

Footnotes

Shares were transferred from direct ownership to ownership under the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
Included in this number are 58,591 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,755 of which were granted on March 8, 2017 and shall vest through March 8, 2020 and 6,334 of which were granted on March 8, 2016 and shall vest through March 8, 2019.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.